Our experience in the treatment of malignant tumors of the bronchi and lungs
Abstract
The authors relate their experience in the treatment of malignant tumors of the bronchi and lungs in the period from January 1st 1992 to December 31st 2003 in the Surgical Clinic of the Clinical Hospital Split in Split. During that period 486 patients underwent an operation for malignant lung diseases. Of this number 436 (89.71%) were men and only 50 (10.29%) were women. The patients with malignant lung diseases were from 34 to 78 years of age, the greatest incidence being with the patients in their sixties. The most frequent operation performed was lobectomy 297 (61.11%), followed by pulmectomy 105 (21.62%), explorative thoracotomy 52 (10.7%) and finally bilobectomy 32 (6.58%). Patohistological analysis has shown that all the operatively treated patients 313 (64.4%) had squamous cell carcinoma, 139 (28.6%) adenocarcinoma and 34 (7%) patients had other forms of cancer. Less than one fourth of patients 97 (19.96%) had localized lung tumor (1st stage), while almost one third of the patients 181 (37.24%) had locally advanced lung carcinoma. The rest of the patients, 208 of them, had carcinoma in later stages which gave them less chance of being cured. We had early postoperative mortality (within 30 days following the operation) in three (0.62%) cases and this was caused by cardiorespiratory insufficiency. We think that surgical resection is the only therapeutic method which can cure a patient. Hence it should be performed in all indicated cases as early as possible.
Downloads
Copyright (c) 2005 Acta Chirurgica Croatica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby authorize the Acta Chirurgica Croatica (ACC) to publish their work.
The authors are aware that although ACC is Open Access journal, the copyright of all material published is vested in ACC. Open access articles are freely available to read, download, and share from the time of publication under the terms of the Creative Commons License Attribution ‐ NonCommerical No Derivative (CC BY‐NC‐ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission of ACC and appropriate acknowledgment of its source. The authors permit ACC to allow third parties to copy any part of the work without asking for permission, provided that the reference to the source is given and that this is not done for commercial purposes. Except for copyright, other proprietary rights related to the work (e.g., patent or other rights to any process or procedure) shall be retained by the author. To reproduce any text, figures, tables, or illustrations from this work in future works of their own, the author must obtain written permission from ACC.
Each of the author(s) hereby also grants permission to ACC to use such author’s name and likeness in connection with any past, present or future promotional activity by ACC, including, but not limited to, promotions for upcoming issues or publications, circulation solicitations, advertising or other publications in connection with ACC. Also, each of the author(s) hereby grants permission to ACC to use the manuscript in editorial research related to the improvement of editorial conduct, decision making, and issues related to peer review.
Each of the author(s) hereby releases and shall indemnify and hold harmless ACC and its successors, assigns, licensees, officers, directors, employees, and their respective heirs and representatives from and against any and all liabilities, losses, damages and expenses arising out of any claims of any kind that may be asserted against any of them based in whole or in part on any breach of the author(s)’ representations or warranties herein or in the work or anything contained in the work, including but not limited to any claims for copyright infringement or violation of any rights of privacy or publicity.
